ALL-IN trial
HEART FAILURE
In short, the ALL-IN trial was a cluster-randomized trial in which primary care practices were randomized to provide either integrated AF care or usual care to patients aged 65 years and older. Highly similar to the ABC approach recommended by the ESC guidelines, our integrated AF care intervention comprised of (i) anticoagulation monitoring in primary care, (ii) quarterly checkups for AF symptoms and comorbidities with special attention for the development of heart failure, and (iii) easy-access consultation with AF- and anticoagulation specialists. In total 26 practices with in total 1,240 patients were included between 2015 and 2017 and the follow-up duration was at least two years. The study design and results of the trial have been described in more detail previously [